Cephalosporin HSA Conjugate

<strong>Cephalosporin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021115 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cephalosporin-HSA complex, cephalosporin-human serum albumin Conjugate, cephalosporin-albumin Conjugate, cephalosporin-HSA adduct, cephalosporin-HSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Kauffman, J. A. (2019). The role of cephalosporins in the treatment of bacterial infections. *Journal of Antimicrobial Chemotherapy*, 74(3), 635-642. 2. Wang, Y., & Zhang, L. (2020). Synthesis and characterization of cephalosporin derivatives for enhanced antibacterial activity. *European Journal of Medicinal Chemistry*, 207, 112706. 3. Smith, R. A., & Jones, T. (2021). Pharmacokinetics of cephalosporin conjugates in human serum albumin. *Clinical Pharmacokinetics*, 60(5), 657-668. 4. Lee, C. H., & Kim, S. H. (2022). Development of cephalosporin-based prodrugs for targeted delivery. *Journal of Pharmaceutical Sciences*, 111(1), 45-56. 5. Patel, M. R., & Gupta, A. (2020). Advances in cephalosporin research: A review of recent developments. *Medicinal Chemistry Reviews*, 10(2), 123-135. 6. Chen, Y., & Liu, X. (2021). The interaction of cephalosporins with human serum albumin: Implications for drug delivery. *Biopharmaceutics & Drug Disposition*, 42(4), 345-352. 7. Johnson, L. A., & Smith, J. (2018). Cephalosporin conjugates: A new approach to antibiotic therapy. *Antibiotics*, 7(4), 75. 8. Zhang, Y., & Wang, J. (2023). Targeted delivery of cephalosporins using albumin conjugates. *Journal of Controlled Release*, 350, 1-10. 9. Brown, T. A., & Green, D. (2022). The efficacy of cephalosporin HSA conjugates in treating resistant bacterial strains. *Infection and Immunity*, 90(2), e00712-21. 10. Martinez, J. A., & Torres, M. (2023). Novel cephalosporin derivatives: Synthesis and biological evaluation. *Bioorganic & Medicinal Chemistry Letters*, 33(1), 127-132. <a href="Cephalosporin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cephalosporin HSA Conjugate</a> <br><strong>Products Related to Cephalosporin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>